骨移植替代品市场-依材料类型[同种异体移植（DBM）、合成（聚合物、陶瓷、复合材料）]、应用（脊椎融合、牙科、关节重建、足踝、颅颚面、长骨）、最终用途-全球预测, 2024-2032

Bone Graft Substitutes Market-By Material Type [Allograft (DBM), Synthetic (Polymer, Ceramics, Composites)], Application (Spinal Fusion, Dental, Joint Reconstruction, Foot & Ankle, Craniomaxillofacial, Long Bone), End-use-Global Forecast, 2024-2032

出版日期: 2024年01月31日 | 出版商:

Global Market Insights Inc. | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于导致骨折和缺损的创伤病例数量不断增加，2024年至2032年全球骨移植替代品市场规模将创下6.6%的CAGR。骨移植替代品在帮助创伤患者骨再生和修復方面发挥着至关重要的作用。创新生物材料和合成替代品等医疗技术的快速进步正在提高骨移植解决方案的有效性和可用性。这些因素的结合将推动该行业在满足创伤患者的需求和改善手术结果方面的成长。例如，2023 年 5 月，Royal Biologics 推出了 Bio-Reign 3D 骨移植替代品，这是其产品线中的新型产品，设计为在植入时具有射线可穿透性。

骨移植替代品市场分为材料类型、应用、最终用途和区域。

根据材料类型，在合成替代品的优势（例如可用性、成本效益和降低疾病传播风险）的推动下，合成细分市场将实现显着的收入份额，到 2032 年CAGR为 7%。合成骨移植物，包括陶瓷和聚合物，具有非常模仿天然骨的特性，可促进骨再生。此外，在骨科和牙科手术中越来越多地采用合成材料，以及对创新和生物相容性骨移植替代品的需求不断增长，将促进该领域的成长。

由于牙科疾病的盛行率不断上升以及对牙植体和手术的需求不断增长，牙科应用领域的骨移植替代品市场从 2024 年到 2032 年的CAGR将达到 7.3%。骨移植替代品在牙科应用中发挥着至关重要的作用，有助于种植体植入和牙周治疗的骨再生。此外，牙科技术和材料的进步正在推动这些替代品的采用。随着人们对口腔健康和美观的日益重视，产品在牙科应用中的采用率将进一步飙升。

在老年人口不断扩大、骨科疾病盛行率上升以及先进医疗技术日益普及的推动下，亚太地区骨移植替代品产业规模从 2024 年到 2032 年将呈现 7.6% 的CAGR。中国和印度等国家因其庞大的患者群体和改善的医疗基础设施而极大地促进了骨移植替代品的需求。此外，对再生医学的日益关注以及具有成本效益的骨移植替代品的可用性的提高将进一步促进区域市场的扩张。

产业生态系统分析
产业影响力
- 成长动力
  - 骨科疾病盛行率增加
  - 骨移植材料的技术进步
  - 外科手术数量不断增加
- 产业陷阱与挑战
  - 骨移植手术费用高
  - 有限的报销政策
成长潜力分析
监管环境
技术景观
波特的分析
PESTEL分析
报销场景
未来市场趋势
缺口分析

第 4 章：竞争格局

介绍
公司矩阵分析
公司市占率分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按材料类型，2018 年 - 2032 年

主要趋势
同种异体移植物
- 去矿骨基质（DBM）
- 其他同种异体移植物
合成的
- 聚合物
- 陶瓷
- 复合材料
- 骨形态发生蛋白 (BMP)

第 6 章：市场估计与预测：按应用，2018 - 2032

主要趋势
脊椎融合术
牙科
关节重建
脚和脚踝
颅颚面
长骨

第 7 章：市场估计与预测：按最终用途，2018 - 2032 年

主要趋势
医院
专科诊所
其他最终用户

第 8 章：市场估计与预测：按地区划分，2018 年 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 9 章：公司简介

AlloSource
Baxter International Inc.
DePuy Synthes (Johnson & Johnson Inc.)
Geistlich Pharma AG
Medtronic plc
NuVasive, Inc.
Orthofix US LLC.
OST Laboratories
Smith + Nephew
Stryker Corporation
Zimmer Biomet Holdings, Inc.

简介目录

Product Code: 7993

Global Bone Graft Substitutes Market size will record 6.6% CAGR from 2024 to 2032, attributed to the increasing number of trauma cases resulting in bone fractures and defects. Bone graft substitutes play a crucial role in aiding bone regeneration and repair in trauma patients. Rapid advancements in medical technology, such as innovative biomaterials and synthetic substitutes are enhancing the effectiveness and availability of bone grafting solutions. This combination of factors will propel the industry growth in meeting the needs of trauma patients and improving surgical outcomes. For instance, in May 2023, Royal Biologics introduced the Bio-Reign 3D bone graft substitute, a novel product in its line designed to be radiolucent upon implantation.

The bone graft substitutes market is divided into material type, application, end-use, and region.

Based on material type, the synthetic segment will achieve a noteworthy revenue share, depicting 7% CAGR through 2032, fueled by advantages of synthetic substitutes, such as availability, cost-effectiveness, and reduced risk of disease transmission. Synthetic bone grafts, including ceramics and polymers, offer properties that closely mimic natural bone for promoting bone regeneration. Additionally, the increasing adoption of synthetic materials in orthopedic and dental procedures along with the rising demand for innovative and biocompatible bone graft substitutes will add to the segment growth.

Bone graft substitutes market from the dental application segment will garner 7.3% CAGR from 2024 to 2032, due to the increasing prevalence of dental disorders and the rising demand for dental implants and procedures. Bone graft substitutes play a vital role in dental applications in aiding in bone regeneration for implant placements and periodontal treatments. Moreover, advancements in dental technology and materials are fueling the adoption of these substitutes. With the growing emphasis on oral health and aesthetics, the product adoption will further soar in dental applications.

Asia Pacific bone graft substitutes industry size will demonstrate 7.6% CAGR from 2024 to 2032, driven by the expanding geriatric population, rising prevalence of orthopedic conditions, and the increasing adoption of advanced medical technologies. Countries like China and India are significantly contributing to the demand for bone graft substitutes with their large patient population and improved healthcare infrastructure. Additionally, the growing focus on regenerative medicine and the higher availability of cost-effective bone graft substitutes will further bolster the regional market expansion.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of orthopedic disorders
  - 3.2.1.2 Technological advancements in bone graft materials
  - 3.2.1.3 Rising number of surgical procedures
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of bone graft procedures
  - 3.2.2.2 Limited reimbursement policies
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis
3.8 Reimbursement scenario
3.9 Future market trends
3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Material Type, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Allograft
- 5.2.1 Demineralized bone matrix (DBM)
- 5.2.2 Other allografts
5.3 Synthetic
- 5.3.1 Polymers
- 5.3.2 Ceramics
- 5.3.3 Composites
- 5.3.4 Bone morphogenic proteins (BMP)

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Spinal fusion
6.3 Dental
6.4 Joint reconstruction
6.5 Foot & ankle
6.6 Craniomaxillofacial
6.7 Long bone

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Specialty clinics
7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa